\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\:\\ patient\\ has\\ pain\\ with\\ ambulation\\.\\ knees\\ \\ no\\ pain\\ to\\ palpation\\,\\ no\\ nodules\\,\\ no\\ muscle\\ weakness\\,\\ no\\ warmth\\ to\\ touch\\,\\ no\\ erythema\\.\\ \\ \ \(0\)\
\-\ \\(lt\\ knee\\)\\:\\ full\\ rom\\.\\ \\ \ \(0\)\
\-\ \\(rt\\ knee\\)\\:some\\ generalized\\ swelling\\,\\ \\+\\ pain\\ with\\ extension\\,\\ decreased\\ rom\\ secondary\\ to\\ pain\ \(0\)\
\-\ pertinent\\ laboratory\\ studies\\ showed\\ esr\\ 65\\ \\(h\\)\\,\\ ana\\ \\(\\-\\)\\,\\ rheumatoid\\ factor\\ 10\\.8\\ \\(0\\-14\\)\\,\\ urate\\ 4\\.3\\,\\ c\\-reactive\\ protein\\ 0\\.219\\,\\ glucose\\ 107\\,\\ k\\ 5\\.1\\,\\ na\\ 136\\,\\ gfr\\ nml\\,\\ tsh\\ nml\\,\\ all\\ remaining\\ labs\\ within\\ normal\\ limits\ \(0\)\
\-\ physical\\ therapy\ \(90\)\
\-\ nsaids\\ as\\ tolerated\ \(0\)\
\-\ narcotics\\ for\\ pain\\ control\ \(0\)\
\-\ prophylactic\\ low\\ dose\\ colchicine\ \(0\)\
\-\ intraarticular\\ glucocorticoid\\ injections\ \(0\)\
\-\ aspiration\\ of\\ any\\ future\\ effusions\ \(0\)\
\-\ chondrocalcinosis\\ of\\ the\\ menisci\\ of\\ both\\ knees\\ with\\ severe\\ patellofemoral\\ joint\\ space\\ narrowing\\ bilaterally\\.\\ \\ medial\\ and\\ lateral\\ intraarticular\\ joint\\ spaces\\ are\\ preserved\\ bilaterally\\,\\ as\\ demonstrated\\ on\\ the\\ ap\\ radiograph\\.\\ a\\ suprapatellar\\ effusion\\ of\\ the\\ right\\ knee\\ is\\ present\\.\\ no\\ left\\ knee\\ effusion\\ is\\ seen\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ \\(cppd\\)\\ crystal\\ deposition\\ disease\ \(0\)\
\-\ diseases\\ associated\\ with\\ cppd\ \(0\)\
\-\ gout\ \(75\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ hemochromatosis\ \(13\)\
\-\ hypophosphatasia\ \(2\)\
\-\ hypothyroidism\ \(39\)\
\-\ neuropathic\\ osteoarthropathy\ \(3\)\
\-\ amyloidosis\ \(26\)\
\-\ long\\-term\\ corticosteroid\\ therapy\ \(0\)\
\-\ cc\\/hpi\\:\\ \\ 72\\ y\\/o\\ female\\ presents\\ with\\ history\\ of\\ several\\ weeks\\ bilateral\\ persistent\\ knee\\ pain\\ who\\ now\\ complains\\ of\\ an\\ increase\\ in\\ right\\ knee\\ pain\\ of\\ abrupt\\ onset\\ over\\ past\\ few\\ days\\.\\ \\ the\\ pain\\ is\\ minimally\\ relieved\\ with\\ percocet\\,\\ and\\ self\\-rated\\ as\\ 9\\/10\\.\\ \\ the\\ patient\\ denied\\ any\\ precipitating\\ trauma\\,\\ constitutional\\ symptoms\\ of\\ fatigue\\/fever\\/weight\\ change\\,\\ and\\ claims\\ no\\ arthralgias\\/myalgias\\/neuropathic\\ pain\\.\\ patient\\ has\\ swelling\\ and\\ warmth\\ associated\\ with\\ the\\ joint\\ pain\\.\\ \\ social\\ history\\ is\\ significant\\ for\\ a\\ positive\\ current\\ smoking\\ profile\\ and\\ no\\ etoh\\ use\\.\ \(0\)\
\-\ this\\ patient\\ with\\ cppd\\,\\ with\\ the\\ classic\\ linear\\ calcifications\\ in\\ the\\ menisci\\ of\\ both\\ knees\\ and\\ the\\ osteoarthritic\\ changes\\ at\\ the\\ patellofemoral\\ joint\\,\\ should\\ be\\ compared\\ against\\ the\\ radiographic\\ findings\\ in\\ hadd\\,\\ with\\ more\\ dense\\ calcifications\\,\\ so\\ one\\ may\\ appreciate\\ the\\ difference\\ between\\ the\\ two\\ pathologic\\ processes\\ on\\ plain\\ film\\.\ \(0\)\
\-\ \\ \\ \\ \\ with\\ this\\ patient\\'s\\ history\\ of\\ stomach\\ cancer\\ and\\ her\\ age\\,\\ nsaids\\ might\\ not\\ be\\ the\\ first\\ choice\\ for\\ treatment\\.\\ \\ intraarticular\\ steroid\\ injections\\ in\\ conjunction\\ with\\ aspiration\\ of\\ effusion\\ \\(right\\ knee\\)\\ could\\ providelocal\\ disease\\ control\\.\ \(0\)\
\-\ \\ \\ \\ \\ although\\ this\\ patient\\'s\\ temperature\\ was\\ normal\\ and\\ crystal\\ arthropathies\\ are\\ more\\ prevalent\\ in\\ an\\ older\\ population\\,\\ an\\ important\\ diagnosis\\ to\\ rule\\ out\\ is\\ septic\\ arthritis\\.\\ \\ if\\ the\\ patient\\ was\\ febrile\\ with\\ elevated\\ wbc\\ count\\ and\\ the\\ knees\\ was\\ warm\\ with\\ erythema\\,\\ infection\\ could\\ be\\ considered\\,\\ \\ and\\ joint\\ aspiration\\ may\\ be\\ done\\ with\\ subsequent\\ treatment\\ if\\ infection\\ present\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ knee\\:\\ 0\\.048198744573159855\ \(0\)\
\-\ knees\\:\\ 0\\.044136629531168356\ \(0\)\
\-\ intraarticular\\:\\ 0\\.03988203386606855\ \(0\)\
\-\ cppd\\:\\ 0\\.03587687479654235\ \(0\)\
\-\ joint\\:\\ 0\\.03070476950046757\ \(0\)\
\-\ aspiration\\:\\ 0\\.026853511207896353\ \(0\)\
\-\ patellofemoral\\:\\ 0\\.026588022577379033\ \(0\)\
\-\ menisci\\:\\ 0\\.026333985182534818\ \(0\)\
\-\ nml\\:\\ 0\\.02609368642133359\ \(0\)\
\-\ crystal\\:\\ 0\\.025865716224055587\ \(0\)\
\-\ warmth\\:\\ 0\\.02453191803538742\ \(0\)\
\-\ injections\\:\\ 0\\.023640048277777857\ \(0\)\
\-\ pain\\:\\ 0\\.023191292611794107\ \(0\)\
\-\ effusion\\:\\ 0\\.021647826134702678\ \(0\)\
\-\ nsaids\\:\\ 0\\.020492559131446812\ \(0\)\
\-\ rom\\:\\ 0\\.020050903692277015\ \(0\)\
\-\ 0\\-14\\:\\ 0\\.019590040942147773\ \(0\)\
\-\ 0\\.219\\:\\ 0\\.019590040942147773\ \(0\)\
\-\ cc\\/hpi\\:\\ 0\\.019590040942147773\ \(0\)\
\-\ self\\-rated\\:\\ 0\\.019590040942147773\ \(0\)\
\-\ fatigue\\/fever\\/weight\\:\\ 0\\.019590040942147773\ \(0\)\
\-\ arthralgias\\/myalgias\\/neuropathic\\:\\ 0\\.019590040942147773\ \(0\)\
\-\ providelocal\\:\\ 0\\.019590040942147773\ \(0\)\
\-\ erythema\\:\\ 0\\.018668435142778838\ \(0\)\
\-\ control\\:\\ 0\\.017313499991726104\ \(0\)\
\-\ arthropathies\\:\\ 0\\.017148680300663084\ \(0\)\
\-\ \\,\\:\\ 0\\.01684418185440899\ \(0\)\
\-\ urate\\:\\ 0\\.016509386806325795\ \(0\)\
\-\ colchicine\\:\\ 0\\.015608353232752096\ \(0\)\
\-\ glucocorticoid\\:\\ 0\\.015608353232752096\ \(0\)\
\-\ percocet\\:\\ 0\\.015608353232752096\ \(0\)\
\-\ hadd\\:\\ 0\\.015608353232752096\ \(0\)\
\-\ no\\:\\ 0\\.015296784901400923\ \(0\)\
\-\ 107\\:\\ 0\\.0152657961664693\ \(0\)\
\-\ 136\\:\\ 0\\.014969059738414805\ \(0\)\
\-\ gfr\\:\\ 0\\.014969059738414805\ \(0\)\
\-\ narcotics\\:\\ 0\\.014969059738414805\ \(0\)\
\-\ appreciate\\:\\ 0\\.014969059738414805\ \(0\)\
\-\ 10\\.8\\:\\ 0\\.014707319659178396\ \(0\)\
\-\ hypophosphatasia\\:\\ 0\\.014473185179938784\ \(0\)\
\-\ precipitating\\:\\ 0\\.014473185179938784\ \(0\)\
\-\ claims\\:\\ 0\\.014473185179938784\ \(0\)\
\-\ dihydrate\\:\\ 0\\.014261384780373617\ \(0\)\
\-\ prevalent\\:\\ 0\\.014261384780373617\ \(0\)\
\-\ calcifications\\:\\ 0\\.014120727798367788\ \(0\)\
\-\ c\\-reactive\\:\\ 0\\.014068026164841105\ \(0\)\
\-\ could\\:\\ 0\\.014011368639246898\ \(0\)\
\-\ suprapatellar\\:\\ 0\\.013890153481122136\ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.013890153481122136\ \(0\)\
\-\ 5\\.1\\:\\ 0\\.013428732670503814\ \(0\)\
\-\ patient\\:\\ 0\\.013324763369810479\ \(0\)\
\-\ 9\\/10\\:\\ 0\\.013294011288689516\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.013166992591267409\ \(0\)\
\-\ osteoarthritic\\:\\ 0\\.013166992591267409\ \(0\)\
\-\ lt\\:\\ 0\\.012932858112027793\ \(0\)\
\-\ ana\\:\\ 0\\.012932858112027793\ \(0\)\
\-\ conjunction\\:\\ 0\\.012932858112027793\ \(0\)\
\-\ ambulation\\:\\ 0\\.01282443552498461\ \(0\)\
\-\ chondrocalcinosis\\:\\ 0\\.01282443552498461\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.01282443552498461\ \(0\)\
\-\ neuropathic\\:\\ 0\\.012721057712462628\ \(0\)\
\-\ swelling\\:\\ 0\\.012652492728805033\ \(0\)\
\-\ difference\\:\\ 0\\.012622276017860775\ \(0\)\
\-\ constitutional\\:\\ 0\\.012527699096930116\ \(0\)\
\-\ bilaterally\\:\\ 0\\.012474245504550681\ \(0\)\
\-\ 4\\.3\\:\\ 0\\.012436983553551773\ \(0\)\
\-\ etoh\\:\\ 0\\.012436983553551773\ \(0\)\
\-\ rt\\:\\ 0\\.012349826413211145\ \(0\)\
\-\ profile\\:\\ 0\\.012349826413211145\ \(0\)\
\-\ corticosteroid\\:\\ 0\\.012185142030647321\ \(0\)\
\-\ warm\\:\\ 0\\.012107161319955609\ \(0\)\
\-\ any\\:\\ 0\\.011959266813654638\ \(0\)\
\-\ tolerated\\:\\ 0\\.011958958265514116\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.011888405602592826\ \(0\)\
\-\ abrupt\\:\\ 0\\.011753684220778526\ \(0\)\
\-\ be\\:\\ 0\\.011713393096390481\ \(0\)\
\-\ prophylactic\\:\\ 0\\.011689267472171298\ \(0\)\
\-\ \\(\\:\\ 0\\.011236737963793385\ \(0\)\
\-\ preserved\\:\\ 0\\.011231818462828745\ \(0\)\
\-\ relieved\\:\\ 0\\.011180730644551638\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.011130790964880398\ \(0\)\
\-\ \\)\\:\\ 0\\.011099475210651412\ \(0\)\
\-\ social\\:\\ 0\\.011081948949949785\ \(0\)\
\-\ infection\\:\\ 0\\.011040073662545809\ \(0\)\
\-\ febrile\\:\\ 0\\.010941551390790826\ \(0\)\
\-\ 72\\:\\ 0\\.01076717002314306\ \(0\)\
\-\ might\\:\\ 0\\.01076717002314306\ \(0\)\
\-\ temperature\\:\\ 0\\.010725631949782719\ \(0\)\
\-\ pertinent\\:\\ 0\\.010684856086075617\ \(0\)\
\-\ gout\\:\\ 0\\.01064481496273633\ \(0\)\
\-\ against\\:\\ 0\\.01064481496273633\ \(0\)\
\-\ deposition\\:\\ 0\\.010605482569182107\ \(0\)\
\-\ future\\:\\ 0\\.010528846622357285\ \(0\)\
\-\ long\\-term\\:\\ 0\\.010491497470543107\ \(0\)\
\-\ k\\:\\ 0\\.010348078534681835\ \(0\)\
\-\ tsh\\:\\ 0\\.010313624786824134\ \(0\)\
\-\ if\\:\\ 0\\.010305526372358379\ \(0\)\
\-\ processes\\:\\ 0\\.010279697070977938\ \(0\)\
\-\ touch\\:\\ 0\\.010246279565723406\ \(0\)\
\-\ na\\:\\ 0\\.010246279565723406\ \(0\)\
\-\ therapy\\:\\ 0\\.010153959094402724\ \(0\)\
\-\ glucose\\:\\ 0\\.01014894040426031\ \(0\)\
\-\ \\:\\:\\ 0\\.010046887253250356\ \(0\)\
\-\ steroid\\:\\ 0\\.010025451846138508\ \(0\)\
\-\ h\\:\\ 0\\.009995622912067084\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.009966189074844816\ \(0\)\
\-\ septic\\:\\ 0\\.009966189074844816\ \(0\)\
\-\ generalized\\:\\ 0\\.009937140004695142\ \(0\)\
\-\ dose\\:\\ 0\\.009937140004695142\ \(0\)\
\-\ population\\:\\ 0\\.009908465771726459\ \(0\)\
\-\ remaining\\:\\ 0\\.009880156825554393\ \(0\)\
\-\ minimally\\:\\ 0\\.009880156825554393\ \(0\)\
\-\ choice\\:\\ 0\\.009824598376209021\ \(0\)\
\-\ \\+\\:\\ 0\\.009797331503782767\ \(0\)\
\-\ protein\\:\\ 0\\.009743781389162631\ \(0\)\
\-\ both\\:\\ 0\\.00969866662527165\ \(0\)\
\-\ factor\\:\\ 0\\.009691491394917756\ \(0\)\
\-\ effusions\\:\\ 0\\.009691491394917756\ \(0\)\
\-\ esr\\:\\ 0\\.00961529345385413\ \(0\)\
\-\ smoking\\:\\ 0\\.009590463896969407\ \(0\)\
\-\ diseases\\:\\ 0\\.009565908705443663\ \(0\)\
\-\ older\\:\\ 0\\.009565908705443663\ \(0\)\
\-\ more\\:\\ 0\\.00949856137472074\ \(0\)\
\-\ spaces\\:\\ 0\\.009356329417729792\ \(0\)\
\-\ physical\\:\\ 0\\.009317801198138837\ \(0\)\
\-\ calcium\\:\\ 0\\.009290643190526362\ \(0\)\
\-\ 65\\:\\ 0\\.009269172277389168\ \(0\)\
\-\ denied\\:\\ 0\\.009247906830686612\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.008969766513011042\ \(0\)\
\-\ dense\\:\\ 0\\.008969766513011042\ \(0\)\
\-\ associated\\:\\ 0\\.008962055830700897\ \(0\)\
\-\ current\\:\\ 0\\.008896297930209067\ \(0\)\
\-\ complains\\:\\ 0\\.00882518075001757\ \(0\)\
\-\ so\\:\\ 0\\.008640588308465097\ \(0\)\
\-\ as\\:\\ 0\\.00861718337262752\ \(0\)\
\-\ present\\:\\ 0\\.008577816684140803\ \(0\)\
\-\ few\\:\\ 0\\.00854601138753444\ \(0\)\
\-\ important\\:\\ 0\\.008530632625657609\ \(0\)\
\-\ stomach\\:\\ 0\\.008396812936784154\ \(0\)\
\-\ \\'s\\:\\ 0\\.008373540526075756\ \(0\)\
\-\ may\\:\\ 0\\.008330348306213884\ \(0\)\
\-\ pathologic\\:\\ 0\\.008311876908294826\ \(0\)\
\-\ count\\:\\ 0\\.008257004435871776\ \(0\)\
\-\ full\\:\\ 0\\.008203454321251642\ \(0\)\
\-\ arthritis\\:\\ 0\\.008112738777873298\ \(0\)\
\-\ linear\\:\\ 0\\.008050136829058417\ \(0\)\
\-\ compared\\:\\ 0\\.008037825317112605\ \(0\)\
\-\ increase\\:\\ 0\\.007965355126915359\ \(0\)\
\-\ rule\\:\\ 0\\.007929987448457805\ \(0\)\
\-\ an\\:\\ 0\\.0078777657618982\ \(0\)\
\-\ nodules\\:\\ 0\\.007872264145339447\ \(0\)\
\-\ done\\:\\ 0\\.007872264145339447\ \(0\)\
\-\ history\\:\\ 0\\.007868096918047223\ \(0\)\
\-\ limits\\:\\ 0\\.007827141331648902\ \(0\)\
\-\ treatment\\:\\ 0\\.0076871864871150535\ \(0\)\
\-\ considered\\:\\ 0\\.0076656497976547704\ \(0\)\
\-\ narrowing\\:\\ 0\\.007614325986999994\ \(0\)\
\-\ persistent\\:\\ 0\\.007574103672236399\ \(0\)\
\-\ use\\:\\ 0\\.007505420255651784\ \(0\)\
\-\ change\\:\\ 0\\.00740160331216854\ \(0\)\
\-\ subsequent\\:\\ 0\\.00739240155068847\ \(0\)\
\-\ film\\:\\ 0\\.007293619856086618\ \(0\)\
\-\ classic\\:\\ 0\\.007276121952906827\ \(0\)\
\-\ radiographic\\:\\ 0\\.007207476426197186\ \(0\)\
\-\ has\\:\\ 0\\.007131999868863458\ \(0\)\
\-\ studies\\:\\ 0\\.007092224261731466\ \(0\)\
\-\ weakness\\:\\ 0\\.00705246967339641\ \(0\)\
\-\ laboratory\\:\\ 0\\.006997981635231258\ \(0\)\
\-\ ap\\:\\ 0\\.006944797710316529\ \(0\)\
\-\ wbc\\:\\ 0\\.006922388556835138\ \(0\)\
\-\ muscle\\:\\ 0\\.006820700518725211\ \(0\)\
\-\ extension\\:\\ 0\\.006778505158181452\ \(0\)\
\-\ labs\\:\\ 0\\.006604386682078084\ \(0\)\
\-\ was\\:\\ 0\\.006588516814757912\ \(0\)\
\-\ now\\:\\ 0\\.006491367977114772\ \(0\)\
\-\ elevated\\:\\ 0\\.006442925247464584\ \(0\)\
\-\ although\\:\\ 0\\.0064131761790591196\ \(0\)\
\-\ this\\:\\ 0\\.0064075814220942206\ \(0\)\
\-\ first\\:\\ 0\\.006372185410635227\ \(0\)\
\-\ palpation\\:\\ 0\\.006337642400773449\ \(0\)\
\-\ space\\:\\ 0\\.006281237793503632\ \(0\)\
\-\ out\\:\\ 0\\.006275675281907814\ \(0\)\
\-\ is\\:\\ 0\\.006247675315385841\ \(0\)\
\-\ cancer\\:\\ 0\\.006242589476366145\ \(0\)\
\-\ showed\\:\\ 0\\.006226229484274881\ \(0\)\
\-\ disease\\:\\ 0\\.006207722405403129\ \(0\)\
\-\ plain\\:\\ 0\\.006167252694864632\ \(0\)\
\-\ positive\\:\\ 0\\.006161967978409148\ \(0\)\
\-\ several\\:\\ 0\\.00610465074604975\ \(0\)\
\-\ medial\\:\\ 0\\.006073998919089004\ \(0\)\
\-\ should\\:\\ 0\\.006053796759752889\ \(0\)\
\-\ radiograph\\:\\ 0\\.006048774786491917\ \(0\)\
\-\ past\\:\\ 0\\.006033776604325409\ \(0\)\
\-\ between\\:\\ 0\\.006018878969387209\ \(0\)\
\-\ right\\:\\ 0\\.006010878060736111\ \(0\)\
\-\ onset\\:\\ 0\\.005994269390944777\ \(0\)\
\-\ normal\\:\\ 0\\.00595383313155156\ \(0\)\
\-\ examination\\:\\ 0\\.005903162301054589\ \(0\)\
\-\ severe\\:\\ 0\\.005842910666813343\ \(0\)\
\-\ days\\:\\ 0\\.005820165102604394\ \(0\)\
\-\ age\\:\\ 0\\.005779800723431792\ \(0\)\
\-\ some\\:\\ 0\\.0057665072308150205\ \(0\)\
\-\ her\\:\\ 0\\.0057098036855220795\ \(0\)\
\-\ decreased\\:\\ 0\\.00564612533938791\ \(0\)\
\-\ demonstrated\\:\\ 0\\.005572044405459928\ \(0\)\
\-\ changes\\:\\ 0\\.005442328836077912\ \(0\)\
\-\ two\\:\\ 0\\.005438513861368901\ \(0\)\
\-\ weeks\\:\\ 0\\.005389506126446997\ \(0\)\
\-\ all\\:\\ 0\\.005370941087625091\ \(0\)\
\-\ secondary\\:\\ 0\\.005308955481130684\ \(0\)\
\-\ low\\:\\ 0\\.0052803734508142216\ \(0\)\
\-\ y\\/o\\:\\ 0\\.005259175621821424\ \(0\)\
\-\ trauma\\:\\ 0\\.005193352848350954\ \(0\)\
\-\ are\\:\\ 0\\.005177217211242674\ \(0\)\
\-\ one\\:\\ 0\\.00514606974069032\ \(0\)\
\-\ significant\\:\\ 0\\.005106327002342719\ \(0\)\
\-\ who\\:\\ 0\\.004951040909203782\ \(0\)\
\-\ the\\:\\ 0\\.004915530122795584\ \(0\)\
\-\ for\\:\\ 0\\.004860720990951434\ \(0\)\
\-\ over\\:\\ 0\\.004834761311422139\ \(0\)\
\-\ symptoms\\:\\ 0\\.004732572170884753\ \(0\)\
\-\ in\\:\\ 0\\.004682191446002832\ \(0\)\
\-\ bilateral\\:\\ 0\\.0046084838429209865\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004360487401734266\ \(0\)\
\-\ lateral\\:\\ 0\\.004103706768054556\ \(0\)\
\-\ \\-\\:\\ 0\\.004070507686018586\ \(0\)\
\-\ findings\\:\\ 0\\.004041859857311022\ \(0\)\
\-\ and\\:\\ 0\\.004000200127382633\ \(0\)\
\-\ female\\:\\ 0\\.003903911714328519\ \(0\)\
\-\ with\\:\\ 0\\.0039001392029963246\ \(0\)\
\-\ presents\\:\\ 0\\.0038792095455731685\ \(0\)\
\-\ to\\:\\ 0\\.0037961609639376556\ \(0\)\
\-\ seen\\:\\ 0\\.003752505811261534\ \(0\)\
\-\ within\\:\\ 0\\.0036225142408579593\ \(0\)\
\-\ on\\:\\ 0\\.0032172933882907914\ \(0\)\
\-\ of\\:\\ 0\\.002847870686173051\ \(0\)\
\-\ not\\:\\ 0\\.0027440414927598564\ \(0\)\
\-\ at\\:\\ 0\\.0025728070062925176\ \(0\)\
\-\ left\\:\\ 0\\.0021246783761620326\ \(0\)\
\-\ a\\:\\ 0\\.0017626657858604501\ \(0\)\
\-\ \\.\\:\\ 0\\.0013410935858997482\ \(0\)\
